An Open Label, Randomized, 2-period Crossover Study Evaluating Single Dose Food Effect On Apixaban Commercial Image Tablets In Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Apixaban (Primary)
- Indications Thrombosis
- Focus Pharmacokinetics
- Sponsors Pfizer
- 09 Jun 2016 Results of pooled analysis of two phase I studies published in the Clinical Therapeutics
- 24 Oct 2011 Actual patient number added 22 according to ClinicalTrials.gov.
- 24 Oct 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.